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1. Introduction 
Several of the aminoglycoside antibiotics can be 
inactivated by enzymes which occur in gram-negative 
bacteria carrying R-factors. These enzymes are listed 
in table 1. Until recently, R-factor-mediated resistance 
and concomitant inactivation of the gentamicin C 
complex had not been reported. A gentamicin- 
resistant strain of Klebsiella pneumoniae [lo] has now 
been shown to contain an R-factor which mediates 
resistance to the antibiotics of the gentamicin C 
complex. The gentamicins and several related amino- 
glycoside antibiotics are apparently inactivated by 
enzymatic adenylylation. 
2. Materials and methods 
2.1. Strains 
K. pneumoniae strain type 22 #3038 was isolated 
by Dr. C.M.Martin and provided by Dr. J.A.Waitz. 
Table 1 
Aminoglycoside and aminocyclitol inactivating enzymes. 
Antibiotic Inactivating mechanism Reference 
streptomycin, 
spectinomycin adenylylation. L&3,4 
streptomycin phosphorylation 5 
neomycin, kanamycin, 
gentamicin Cr, acetylation 67, g 
neomycin, kanamycin phosphorylation 599 
North-Holland Publishing Company - Amsterdem 
Escherichia coli W2985N is K12, F-, thi-, argc, nap; 
E. coli W677 is K12, F-, thi-, thr-, leu-, lac-, mal-, 
gal-, xyl-, ara-, mtl-, tonA_. 
2.2. R-factor transfer 
Transfer of R-factors was carried out by mixing 
0.5 ml of the R-factor strain (5 X lo8 cells/ml) and 
0.5 ml of the recipient strain (5 X 10’ cells/ml) in 4 
ml of tryptone broth. The mixed culture was allowed 
to stand at 37” for 1 hr and then incubated, with 
shaking, at 37’ for 10 hr. The culture was then 
streaked on a selective plate. For the K. pneumoniae 
X E. coli W2985N cross, the selective medium was 
minimal glucose medium containing arginine (20 
&ml), gentamicin (10 I.cg/ml) and nalidixic acid (30 
pg/ml). In crosses where E. coli W677 was the 
recipient, the selective plates contained threonine 
(20 pg/ml), leucine (20 ccg/ml), and gentamicin (10 
&/ml). The R-factor thus transferred was called 
JR66. 
2.3. Preparation of enzyme extracts 
E. coli JR66/W677 was grown in 40 ml of ML 
broth, harvested in late logarithmic phase of growth, 
and osmotically shocked using a modification of the 
procedure described by Nossal and Heppel [ 1 l] . The 
cells were washed twice at room temperature with 10 
ml 0.01 M tris and 0.03 M NaCl, pH 7.3. The pellet 
was suspended in 10 ml 20% sucrose, 3 X 10T3 M 
EDTA, and 0.033 M tris (pH 7.3), stirred for 10 min 
at room temperature, and centrifuged at 16,000 g 
for 5 min. The pellet was then suspended in 2 ml of 
cold 5 X low4 M MgCla and stirred for 10 min at 2”. 
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The supernatant fluid of a 10 min, 26,000 g centrifuga- 
tion is referred to as the osmotic shockate. 
2.4. Inactivation of antibiotics 
A small scale inactivation of gentamicin Cr was per- 
formed in a 50 ~1 reaction mixture containing 22 
nmoles of gentamicin Cr , 120 nmoles of ATP, 2.5 
moles tris pH 8.1 (at 30”), 0.4 pmole MgCla, 50 
nmoles dithiothreitol, and 25 ~1 of an osmotic shockate 
of JR66/W677 (containing 1 mg/ml protein). This 
mixture was incubated for 3 hr at 30”. To monitor 
the extent of inactivation of gentamicin Ci, 10 j.d of 
the reaction mixture were spotted on a filter paper 
disc which was then placed on a lawn of E. coli W677. 
In the absence of the osmotic shockate or of ATP a 
growth inhibition zone extending 5 mm from the edge 
of the disc was observed. 
2.5. Assay for adenylylating activity 
The adenylation of gentamicin was detected by a 
phosphocellulose paper binding assay that had 
previously been used to monitor the phosphorylation 
[5] , adenylylation [3] , or acetylation [8] of the amino- 
glycoside antibiotics. The reaction mixture contained 
osmotic shockate, 20 nmoles of r4C-ATP or CX-~~P-ATP 
(specific activity, 4 pCi/lunole), 10 nmoles of amino- 
glycoside antibiotic, 2.5 pmoles of tris (pH 8.1 at 300), 
0.4 /Imole of MgC12, and 50 nmoles of dithiothreitol 
in a total volume of 55 ~1. Incubation was at 30’ for 
various periods of time, after which 10 ~1 was pipetted 
onto a 0.75 cm square of phosphocellulose paper 
(Whatman P-81). The squares were allowed to stand 
for 15 SIX to absorb the basic antibiotic, and were 
then immersed in hot, distilled water (70 to 80’) for 2 
min to stop the reaction and remove any radioactivity 
that is not bound to the antibiotic. They were then 
washed several times with large volumes of distilled 
water, dried, and counted in a Packard Tri-Carb 
scintillation spectrometer. Control reactions for non- 
specific binding of 14C-ATP to the paper were run in 
the absence of either enzyme or antibiotic. 
3. Results 
The presence of an R-factor which mediates genta- 
micin resistance in a strain of K. pneumoniae was 
shown by transfer of this resistance to an E. coli 
recipient (W2985N) and subsequent transfer to E. coli 
W677. Simultaneous transfer of resistance to neomycin, 
kanamycin, streptomycin, chloramphenicol, tetra- 
cycline, ampicillin and sulfonamide occurred. The 
resistance patterns of these strains is shown in table 2. 
Since the known aminoglycoside inactivating 
enzymes are released from R-factor strains by cold 
water shocking of sucrose-tris-EDTA-treated cells [2, 
31, an ‘osmotic shockate’ of the gentamicin-resistant 
strain JR66/W677 was prepared and incubated with 
gentamicin Cr as outlined in Materials and methods. 
The antibiotic was inactivated only when magnesium 
and ATP were present in the incubation mixture, 
Table 2 
Resistance characters of strains. 
Strain 
Resistance charactersa 
genCl kan neo str spc cam tet sul amp nal 
Klebsiella pneumoniae 3O38b 
Escherichia coli W677 
Escherichia coli W2985N 
JR66/W2985Nc 
JR66/W677d 
t t t .- t t t + t t 
- - - _ - - - - - - 
_ - - - _ + 
+ + + + - + + + + + 
+ + + t _ + + + + - 
agent,, gentamicin Cl (10 pg disc); ken, kanamycin A (20 rg disc); neo, neomycin B (20 g disc); str, streptomycin (20 fig 
disc); spc, spectinomycin (50 pg disc); cam, chloramphenicol(10 gg disc); ret, tetracycline (10 wg disc); sul, gantrisin (2 mg 
disc); amp, ampicillin (30 pg disc); nul, nalidixic acid (20 fig disc). 
b This strain carries R-factor JR66. 
c W2985N containing R-factor JR66. 
d W677 containing R-factor JR66. 
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Table 3 
Enzymatic adenylylation of aminoglycosides. 
Antibiotic 
cpm incorporated in assaya 
10 min 20 min 
None 40 60 
Gentamicin C 1 7350 14000 
Gentamicin C ra 3000 4500 0 
Gentamicin Cz 2750 5000 
Gentamicin A 9650 18000 
Kanamycin A 5900 11700 
Neomycin B 64 72 
Neamine 60 65 
Streptomycin 53 82 RI Rz ‘%I ‘34 R5 ‘k _----- 
Spectinomycin 32 40 
GENTAMICINS A H OH on on n OH 
a Total amount of radioactivity in a 55 pl reaction, present as Cl0 ” NH2 H H OH CHS 
14C-AMP bound to the antibiotic. For details of incubation C2 CH3 NH2 H H on Cl-IS 
conditions, see Materials and methods. 1000 cpm corresponds C, Cl-k, NHCHJ H H OH CHJ 
to 0.18 nmole of antibiotic-AMP produced in this reaction. 
0Phosphorylation [lo] or N-acetylation (un- Fig. 1. The structures of gentamicin A and of the components 
published results) of gentamicin do not occur in ex- of the gentamicin C complex. a indicates the amino group in 
tracts of the resistant strain of K. pneumoniae 3038 gentamicin Ct, and C2 that has been shown to be enzymati. 
or in E. coli JR66/W677. Since ATP was an absolute 
tally acetylated [8], and b the hydroxyl group in gentamicin 
requirement for the inactivation, we reasoned that the 
A that is phosphorylated [ 51. In the gentamicin C complex, 
ring 1 is purpurosamine, 2 is 2-deoxystreptamine, and 3 is 
modification of gentamicin occurred by adenyiylation, garosamine. 
as has previously been shown for streptomycin [3] . 
The enzymatic. formation of an adenylylated 
derivative of gentamicin was strongly supported by 
the fact that the transfer of radioactivity from r4C-ATP 
or CY-~~P-ATP to cation exchange paper occurred only 
in the presence of gentamicin and the ‘osmotic 
shockate’ from strain JR661W677. Several other 
aminoglycoside antibiotics were also substrates for the 
enzyme, as is shown in table 3. It can be seen that the 
adenylylating enzyme which modifies gentamicin, kana- 
mycin, and related antibiotics is different from the P 
enzyme which has been shown to adenylylate strepto- 
mycin, since neither streptomycin nor spectinomycin 
are substrates. Conversely, gentamicin is not a substrate 
HoMZ 
2 
for the enzyme which adenylylates streptomycin and X Y 
spectinomycin. 
-- 
KANAMYCINS A NH2 OH 
B NH2 NH2 
4. Discussion C OH NH2 
We have demonstrated that a new R-factor, originally 
Fig. 2. The structures of the kanamycins. a indicates the 
present in strains of K. pneumoniae, and subsequently 
amino group in kanamycins A and B that can be enzymatical- 
ly acetylated [7, 81, and b the hydroxyl group that is en- 
transferred to E. coZi, is capable of mediating the enzym- zymatically phosphorylated [91. 
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NEOSAMINE, R’NH2 
GLUCOSAMINE, R-OH 
NEAMINE: R-NH2 
PAROMAMINE: R=OH 
DEOXYSTREPTAMINE 
NEOSAMINE 
NEOMYCIN: R= NH2 
PAfKMCWCIN’ R= OH 
Fig. 3. The structure of neomycin. a indicates the amino 
group in the neamine portion of the antibiotic which can be 
enzymatically acetylated [ 81, and b the hydroxyl group 
which is enzymatically phosphorylated [91. 
atic adenylylation of gentamycin. The same enzyme 
probably inactivates kanamycin (fig. 2) and gentamicin 
A since these drugs are also adenylylated by an osmotic 
shockate of JR66/W677. Although the site of inactiva- 
tion is not known, the absence of hydroxyl groups in 
the purpurosamine ring of the gentamicin C components 
would indicate that the inactivating modification 
occurs on the deoxystreptamine or garosamine rings 
(see fig. 1). The fact that both neomycin B and neamine 
(see fig. 3) are not substrates for this adenylylating 
enzyme further suggests that the modification might 
occur on the garosamine ring of gentamicin C. Alterna- 
tively, it is possible that the enzyme does modify the 
deoxystreptamine ring of the gentamicin antibiotics 
but fails to recognize neomycin and neamine as sub- 
strates. The exact location of the adenylylation is cur- 
rently being determined. 
Strain JR66/W677 also contains the neomycin- 
kanamycin phosphorylating enzyme, and the strepto- 
mycin-phosphorylating enzyme. This strain is there- 
fore resistant to all the aminoglycoside antibiotics in 
current clinical use. The new adenylylating enzyme 
modifies the aminoglycoside antibiotics of the kana- 
mycin-gentamicin group; thus there are three separate 
mechanisms for the inactivation of the kanamycins: 
N-acetylation [6-81 0phosphorylation [9] , and now, 
probably, 0adenylylation. 
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